作者: Aarush Manchanda , Ozlem Soran
DOI: 10.1016/J.JACC.2007.07.024
关键词:
摘要: Between 25,000 and 75,000 new cases of angina refractory to maximal medical therapy standard coronary revascularization procedures are diagnosed each year. In addition, heart failure also places an enormous burden on the U.S. health care system, with estimated economic impact ranging from $20 billion more than $50 per The technique counterpulsation, studied for almost one-half century now, is considered a safe, highly beneficial, low-cost, noninvasive treatment these patients, now patients as well. Recent evidence suggests that enhanced external counterpulsation (EECP) may improve symptoms decrease long-term morbidity via 1 mechanism, including improvement in endothelial function, promotion collateralization, enhancement ventricular oxygen consumption (Vo2), regression atherosclerosis, peripheral training effects similar exercise. Numerous clinical trials last 2 decades have shown EECP be safe effective response rate averaging 70% 80%, which sustained up 5 years. It not only coexisting failure, but quality life exercise capacity left function long-term. Interestingly, has been various potential uses other disease, such restless leg syndrome, sudden deafness, hepatorenal erectile dysfunction, so on. This review summarizes current its use stable future directions.